U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07352878) titled 'Evaluation of the Quality of Life in Patients With Chronic Iron Overload Due to Hemoglobinopathies in Greece.' on Jan. 13.
Brief Summary: This observational clinical study aims to evaluate the HRQoL of thalassemia patients with iron overload in Greece, who are under treatment with deferasirox based on standard clinical practice.
Study Start Date: April 15, 2026
Study Type: OBSERVATIONAL
Condition:
Thalassemia
Iron Overload
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Elpen Pharmaceutical Co. Inc.
Disclaimer: Curated by HT Syndication....